baber/WOPTO huggingface dataset:
Patent AU-2019248310-B2 (AU)
Title: Aromatic compound and preparation method therefor and use thereof
Inventor: XUE TAO
IPC: A61P25/28
Filed: 2019-04-04
Granted: 2022-04-28
Abstract: The present invention relates to an aromatic compound and a preparation method therefor and the use thereof. Specifically, disclosed are a compound as shown in the following general formula (I), or a tautomer, an enantiomer, a diastereomer or a racemate thereof or a mixture thereof, or a pharmaceutically acceptable salt thereof. Also disclosed are a method for preparing the above compound and the use of same in the treatment of nervous system diseases.
Patent AU-2019299631-B2 (AU)
Title: Double row barrel ice maker with overhead extraction
Inventor: JUNGE BRENT ALDEN
IPC: F25C1/04
Filed: 2019-07-02
Granted: 2022-03-10
Abstract: An ice maker (160) includes a mold body (170) with two rows of mold cavities (200) defined in the mold body (170). The ice maker (160) also includes an ejector assembly (180) having a plurality of ejector pads (210) corresponding to the mold cavities (200). The ejector pads (210) are movable between a low position proximate to the floor (202) of a corresponding mold cavity (200) and a high position proximate the opening of each corresponding mold cavity (200). The ejector pads (210) are operable to eject ice from the mold cavities (200) when the ejector assembly (180) moves from the low position to the high position. A related refrigerator appliance (100) is also provided.
Patent AU-2019351797-B2 (AU)
Title: Inter-frequency mobility support for communication systems with dynamic spectrum assignments
Inventor: CHEN ETHAN Y
IPC: H04W16/14
Filed: 2019-09-26
Granted: 2021-07-01
Abstract: Systems and methods for enabling inter-frequency user equipment mobility in shared spectrum communication systems. One example system (100) includes a communication interface (315) coupled to an electronic processor (305). The electronic processor (305) is configured to, for each of a plurality of base stations, determine a location for the base station. The electronic processor (305) is configured to select at least one handover candidate from the plurality of base stations based on the location and at least one base station characteristic. The electronic processor (305) is configured to determine a channel allocation. The electronic processor (305) is configured to generate, based on the channel allocation of the at least one handover candidate, a neighbor channel list (380). The electronic processor (305) is configured to transmit the neighbor channel list (380) via the communication interface (315).
Patent AU-2019456283-B2 (AU)
Title: Mononuclear cell derived NK cells
Inventor: DUGGAL ROHIT
IPC: C12N5/0783
Filed: 2019-07-08
Granted: 2023-06-08
Abstract: Cord blood or peripheral blood NK cells are prepared from whole blood mononuclear cells without the need to isolate CD34+ hematopoietic stem cells or NK cells, and without the need for a feeder layer. Advantageously, the methods presented herein use an enrichment process that uses antiCD16 agonist antibodies, antiCD3 antibodies, and N-803. Moreover, contemplated processes are suitable for adaptation into a fully automated production process (GMP in a box).
Patent AU-2020201840-B2 (AU)
Title: Secure portable, on-demand, microfluidic mixing and dispensing device
Inventor: WILSON MATT
IPC: A61J1/20
Filed: 2020-03-12
Granted: 2021-11-04
Abstract: A secure portable, on-demand, microfluidic mixing and dispensing device comprising a 
plurality of microfluidic pumps, microfluidic valves, at least one heater, a microfluidic mixer 
chip configured to receive and mix microfluidic amounts of a plurality of fluids having 
different viscosities from one another is disclosed. The device includes a plurality of 
pathways defined therein for moving each of the plurality of fluids from a respective tank or 
reservoir to the microfluidic mixer chip. A mix controller is configured to control the 
microfluidic pumps, valves, and at least one heater so that the fluids having different 
viscosities can be accurately mixed at specified microfluidic amounts or volumes according 
to a specified microfluidic recipe, and the microfluidic mixture dispensed from the device.  
The device can be in communication with a software application implemented on a mobile 
compute device, such as a smartphone, and receive instructions for implementing the 
specified microfluidic recipe from the software application such that the operation of device 
components is at the direction of the software application executed on the mobile compute 
device.
WO 2017/180660 PCT/US2017/027064 
U> 3~
Patent AU-2020214760-B2 (AU)
Title: Methods for producing nitroso compound and quinoxaline compound
Inventor: TAMAI RYUJI
IPC: C07C217/92
Filed: 2020-01-31
Granted: 2021-10-21
Abstract: A method for producing a nitroso compound of formula (3), which comprises a process for reacting a compound of formula (1) and a compound of formula (2) with each other by using a tertiary alcohol and a base. (In the formulae, each of R
Patent AU-2020234543-B2 (AU)
Title: Seat assembly and systems
Inventor: BOWMAN ANDREW
IPC: B62B7/12
Filed: 2020-03-09
Granted: 2023-02-23
Abstract: A seat (1000) may include mounting components (1054a. 1054b) that may mate with corresponding components on other assemblies. The seat may include one or more features that may rotate or move to provide for coupling to the one or more assemblies. Assemblies include, but are not limited to, a stroller, a bicycle adapter, a wagon, a booster seat, a camping chair, a high chair, a stadium seat/picnic table, a hiking pack, an infant carrier, a car seat, a booster car seat, or an airline scat.
Patent AU-2020241129-B2 (AU)
Title: Method and system for acoustic feedback cancellation using a known full band sequence
Inventor: KHANAGHA Vahid
IPC: H04R3/02
Filed: 2020-03-10
Granted: 2022-03-17
Abstract: Systems and methods for acoustic feedback cancellation. One method includes transmitting, with a transceiver, a known full-band sequence at a first time. The method includes receiving, via a microphone, a received audio signal including a received copy of the known full-band sequence. The method includes filtering the received audio signal to generate a filtered audio signal, and detecting, based on the filtered audio signal, a second portable communication device in proximity to the portable communication device. The method includes, in response to detecting the second portable communication device, determining, based on the first time and filtered audio signal, an estimated loop delay. The method includes initializing an adaptive feedback cancellation filter based on the estimated loop delay and the plurality of estimated filter coefficients. The method includes determining a plurality of estimated filter coefficients based on the known full-band sequence and the received copy of the known full-band sequence.
Patent AU-2020267632-B2 (AU)
Title: Locking device for a safety bar, passenger accommodation and amusement ride having a locking device of this kind
Inventor: WIEBECK DIRK
IPC: B60R21/02
Filed: 2020-01-23
Granted: 2023-08-03
Abstract: The present invention relates to a locking device (1) for a safety bar (8), comprising a fluid channel (10) having a magneto-rheological fluid (11), a moveable locking element (40) and a magnet device (30), wherein the locking element (40) is coupled to the safety bar (8) and forces the fluid (11) through the fluid channel (10) when the safety bar (8) moves, wherein the fluid channel (10) has at least one channel portion (20), and wherein the magnet device (30) is arranged at least on opposing sidewalls (21) of the channel portion (20) in such a manner that the field lines (31) of the magnetic field from the magnet device (30) can pass through the channel portion (20). The present invention further relates to a passenger accommodation having a safety bar (8) and a locking device (1) and an amusement ride having a locking device (1) according to the invention.
Patent AU-2021200207-B2 (AU)
Title: Automated detection of features and/or parameters within an ocean environment using image data
Inventor: FREESTON BENJAMIN
IPC: G06T7/246
Filed: 2021-01-14
Granted: 2021-11-25
Abstract: Automated detection of features and/or parameters within an ocean environment 
using image data. In an embodiment, captured image data is received from ocean-facing 
camera(s) that are positioned to capture a region of an ocean environment. Feature(s) are 
identified within the captured image data, and parameter(s) are measured based on the 
identified feature(s). Then, when a request for data is received from a user system, the 
requested data is generated based on the parameter(s) and sent to the user system.
3/4 
300 
Image data Image ata iOcean sensor data 320A 
310 and/or 
Ocean physics model 320B 
Pre-processor 
330 
Machine Learning Engine 
340 
Predictive Model 
350 
FIG. 3
Patent AU-2021202186-B2 (AU)
Title: Methods of sensing cross-frequency coupling and neuromodulation
Inventor: DE RIDDER DIRK
IPC: A61N1/05
Filed: 2021-04-09
Granted: 2022-12-01
Abstract: Representative embodiments are directed to detecting neurological activity in a patient. The 
detection of neurological activity includes identifying cross-frequency coupling and 
determining whether the cross-frequency coupling is physiological or pathological. When 
pathological cross-frequency coupling is detected, neurostimulation of one or more sites is 
applied. In some embodiments, an implantable pulse generator is adapted to analyze neural 
activity for pathological cross-frequency coupling and to provide electrical stimulation in 
response to the detected pathological cross-frequency coupling.
Patent AU-2021204782-B2 (AU)
Title: 3,3 Disubstituted 19-nor pregnane compounds, compositions, and uses thereof
Inventor: UPASANI RAVINDRA B
IPC: C07J5/00
Filed: 2021-07-08
Granted: 2023-04-13
Abstract: Provided herein are 3,3-disubstituted 19-nor-steroidal compounds according to Formula (I) 
and (III): 
RR 
R1lb Me O 
R1 l 1l 
M 
R2 H C D 
R 34A B 
R O'O 6 R6 b 
R6 (I) 
R1 
R l Me O 
H C D 
R3,,, A B 
R3' -O 6 Rb 
R4 6Re 
R6 8 (III) 
where R , R2, RI, RI, R4, R6a, Rob, R' , and R' are as defined herein. Compounds of the 
present invention are contemplated useful for the prevention and treatment of a variety of 
CNS-related conditions, for example, treatment of sleep disorders, mood disorders, insomnia, 
anxiety, depression, traumatic brain injury (TBI), stress, and epilepsy.
Patent AU-2021257649-B2 (AU)
Title: Vision-based cell structure recognition using hierarchical neural networks and cell boundaries to structure clustering
Inventor: Wang xin ru
IPC: G06F40/177
Filed: 2021-03-16
Granted: 2024-02-01
Abstract: Methods, systems, and computer program products for vision-based cell structure recognition using hierarchical neural networks and cell boundaries to structure clustering are provided herein. A computer-implemented method includes detecting a style of the given table using at least one style classification model; selecting, based at least in part on the detected style, a cell detection model appropriate for the detected style; detecting cells within the given table using the selected cell detection model; and outputting, to at least one user, information pertaining to the detected cells comprising image coordinates of one or more bounding boxes associated with the detected cells.
Patent AU-2022200722-B2 (AU)
Title: Fitting structure
Inventor: TAWADA KAZUHIRO
IPC: F16B5/07
Filed: 2022-02-03
Granted: 2023-10-12
Abstract: A fitting structure for fitting a first member and a second member together, the fitting 
structure comprising: a fitting projection protruding from a second member opposed surface 
of the first member opposed to the second member toward the second member; a receptacle 
protruding from an opposite surface of the second member on an opposite side from the 
second member opposed surface in an opposite direction from the second member opposed 
surface, the receptacle including an internal receiving space communicating with a through 
hole in the second member, wherein the receptacle including: a fitting portion having a plate 
shape protruding from the opposite surface; a supporting portion protruding from the opposite 
surface such that at least a section of an inner surface of the supporting portion is opposed to 
an inner surface of the fitting portion; and two slits provided between two edges of the fitting 
portion extending in a protruding direction in which the fitting portion protrudes and edges of 
the supporting portion adjacent to the edges of the fitting portion, respectively, the slits 
communicating with the receiving space, the receiving space is defined by the fitting portion 
and the supporting portion, the fitting projection includes a first section disposed in the 
receiving space and a second section fitted to the fitting portion, the fitting projection further 
includes a fitting portion opposed surface being along the protruding direction and including a 
section opposed to the fitting portion, a supporting portion opposed surface being along the 
protruding direction and including a section opposed to the supporting portion, a surface 
extending between one edge of the fitting portion opposed surface and one edge of the 
supporting portion opposed surface and along the protruding direction, and a rib protruding 
from the surface in a direction along the second member opposed surface and being 
connected with the second member opposed surface.
Patent AU-2022203092-B2 (AU)
Title: A fully-human T cell receptor specific for the 369-377 epitope derived from the HER2/Neu (ERBB2) receptor protein
Inventor: POWELL JR DANIEL J
IPC: C07K14/725
Filed: 2022-05-09
Granted: 2024-01-11
Abstract: The present invention relates to compositions and methods for treating 
HER2/Neu (ERBB2) expressing cancer cells. In some embodiments, the invention 
includes an isolated T cell receptor (TCR) having high affinity for and that specifically 
5 binds ERBB2369-377 epitope on a target cell. Other embodiments include a T cell or a 
population of T cells modified to express ERBB2-specific TCR. Further embodiments 
include methods of using ERBB2-specific TCR gene transfer for treating ERBB2 
expressing cancer cells. Also included are methods and pharmaceutical compositions 
comprising the modified T cells for adoptive therapy.
Patent JP-4001703-B2 (JP)
IPC: H01S5/32
Filed: 2000-02-24
Granted: 2007-10-31
Abstract: A light-emitting semiconductor device has (a) a semiconductor body (1) with a layer sequence (7) capable of emitting electromagnetic radiation of a first wavelength range in the UV, blue and/or green region; and (b) a luminescence conversion element which converts radiation of the first wavelength range to radiation of one or more second, different wavelength ranges so that the device emits mixed radiation in the first and second wavelength ranges. Preferably, the luminescence conversion element consists of organic dye molecules in a plastic matrix preferably of silicone, thermoplastic or thermosetting material, especially an epoxide resin or polymethyl methacrylate matrix, and/or an inorganic phosphor (preferably a Ce-doped garnet, especially Ce:YAG) in an epoxide resin or low melting point inorganic glass matrix.
Patent JP-3352662-B2 (JP)
IPC: H02J3/32
Filed: 2000-07-13
Granted: 2002-12-03
Abstract: A power system stabilization system is provided between power generation equipment significantly fluctuating in output and a power system (3) required to maintain a predetermined voltage. In the power system stabilization system, a voltage detection device (51) and a current detection device (52) detect voltage and current, respectively, of the power system (3) and voltage and current thus detected are used to calculate a level of active power required and that of reactive power required which are referred to to provide charging and discharging from a rechargeable battery (10) to the power system via an A-D converter (40). <IMAGE>
Patent JP-4070394-B2 (JP)
IPC: G01N37/00
Filed: 2000-08-15
Granted: 2008-04-02
Abstract: The present invention discloses hybridization assay probes, amplification primers, nucleic acid compositions and methods useful for detecting Borrelia nucleic acids. Hybridization assay probes and amplification primers that selectively detect Lyme disease-associated Borrelia and distinguish those Borrelia from Borrelia hermsii are disclosed. Other hybridization probes selectively detect Borrelia hermsii and not Lyme disease-associated Borrelia are also described.
Patent JP-4428861-B2 (JP)
IPC: A43B3/00
Filed: 1998-11-23
Granted: 2010-03-10
Abstract: Improvements in footwear for sporting purposes requiring the kicking of a ball on or adjacent to an instep of the footwear, there being provided at least one insert (24) for or in addition to the footwear which is attachable to the footwear on or adjacent to the instep such that a concave kicking surface (28) is provided, the radius of curvature of the kicking surface (28) being substantially the same as or slightly greater than the radius of the ball, the at least one insert (24) being of a maximum height at the front of the instep at least as great as the maximum height at the rear of the instep.
Patent JP-4303888-B2 (JP)
IPC: H04N9/804
Filed: 1999-05-31
Granted: 2009-07-29
Abstract: Normally, in an MPEG recorder, during recording, a time stamp counter is locked to the program clock reference of the incoming stream by pulling the clock frequency of a controllable oscillator. During playback, the oscillator is left free running. Playback and recording situation lead to conflicting requirements. A solution is presented that does not have these conflicting requirements, namely by using an adder that adds an increment value to a count value in order to obtain the next count value. The time stamp values are derived from the count values. During recording, the value of the increment value is controllable, and during playback, the value of the increment value is fixed.
Patent JP-4027601-B2 (JP)
IPC: C09D171/02
Filed: 2000-02-03
Granted: 2007-12-26
Abstract: A polyester polymer including at least one polyoxetane block of repeating units derived from polymerizing at least one oxetane monomer having at least one pendant -CH2-O-(CH2)n- Rf group wherein said Rf group is partially or fully fluorinated is described. A preferred process for forming said polymer by reacting the hydroxyl terminated polymer with a polycarboxylic acid under appropriate conditions to form an ester linkage and then adding and reacting that product with polyester forming reactants.
Patent JP-3806629-B2 (JP)
IPC: G02F1/1343
Filed: 2001-09-28
Granted: 2006-08-09
Abstract: PROBLEM TO BE SOLVED: To provide a liquid crystal display device in which remaining parts can be surely cut from each wiring by a simple manufacturing process and an optimum display state can be obtained by preventing the occurrence of a short circuit among the wirings. SOLUTION: In this display device, pixel electrodes 6 are arranged on a substrate 1 in a matrix shape and TFTs (thin film transistors), which are to be connected to these pixel electrodes 6, and signal lines, 5 and scanning lines 2 which are to be connected to these TFTs, are provided. Moreover, protective films 8, 9 are interposed between the signal line 5 and the pixel electrode 6. Then, two lines of signal lines 5 are provided side by side between the pixel electrodes 6 and a groove is formed in the protective films 8, 9 between adjacent signal lines 5.
Patent JP-4773010-B2 (JP)
IPC: A61P43/00
Filed: 2000-06-23
Granted: 2011-09-14
Abstract: The present invention relates to novel compounds, methods of preparing these compounds, and pharmaceutical compositions comprising these compounds. These compounds are carbamate prodrugs that convert to active inhibitors of the IMPDH enzyme in vivo. The compounds and pharmaceutical compositions of this invention are particularly well suited for activation and subsequent inhibition of the IMPDH enzyme activity. Consequently, these prodrugs may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds and compositions of this invention.
Patent JP-4787919-B2 (JP)
IPC: A61K31/553
Filed: 2000-07-26
Granted: 2011-10-05
Abstract: A method and apparatus for lowering the body temperature of a patient while reducing shivering by using a heat exchange device in combination with an alpha2-adrenoreceptor agonist, a non-opiod analgesic monoamine uptake inhibitor or neuropeptide that temporarily reduces shivering. The devices disclosed include a catheter having a heat exchange balloon thereon with heat exchange fluid circulating through the interior of the balloon. The heat exchange balloon is placed in the vasculature of a patient, and heat exchange fluid at a temperature other than the temperature of the blood in the vasculature is circulated through the interior of the balloon to add or remove heat from the blood of the patient. Various alpha2-adrenoreceptor agonistalpha2-adrenoreceptor agonists, non-opiod analgesic monoamine uptake inhibitors and neuropeptides are disclosed including dexmedetomidine, nefopam, neurotensin and anticonvulsant medications and pharmaceutically acceptable salts thereof. A control system for the control of the patient's temperature is disclosed for controlling the patient's temperature in conjunction with administering the alpha2-adrenoreceptor agonist, non-opiod analgesic monoamine uptake inhibitor or neuropeptide.
Patent JP-3995077-B2 (JP)
IPC: B01D5/00
Filed: 2000-08-09
Granted: 2007-10-24
Abstract: Apparatus for the condensation of steam, includes a substructure, a fan supported by the substructure and a plurality of self-supported tube bundles which are arranged in a roof-shaped manner in opposing relationship with respect to a vertical center longitudinal plane and mounted to the substructure above the fan, with each of the tube bundles having an upper tube plate and a lower tube plate. A steam distribution duct is fluidly connected to the upper ends of the tube bundles, whereas condensate collection pipes are fluidly connected to the lower ends of the tube bundles. The upper tube plates of opposite tube bundles so mutually support one another as to allow a limited pivotal movement of the tube bundles, and the condensate collection pipes are so positioned on the substructure as to be shiftable relative to the substructure in parallel relationship to the center longitudinal axis.
Patent JP-3471781-B2 (JP)
IPC: A61K35/12
Filed: 2000-10-06
Granted: 2003-12-02
Abstract: The invention relates to a method for producing a biologically compatible matrix, to a matrix that can be obtained using the method, and to the use thereof. The invention also relates to an implant. The inventive matrix can be produced by dissolving, in water, chitosan in acid, by freezing the solution and by subsequently lyophilizing the same. Excess acid can be removed by neutralizing with a base before or after the lyophilization. The inventive matrix is dimensionally stable and elastic. When implanted, it induces only a minor immunoreaction.
Patent JP-4680464-B2 (JP)
IPC: G03F7/004
Filed: 2000-12-12
Granted: 2011-05-11
Abstract: Imageable elements useful as lithographic printing members are disclosed. The elements contain a substrate, an underlayer, and a top layer. The underlayer contains a combination of polymeric materials that provides resistance both to fountain solution and to aggressive washes, such as a UV wash. The underlayer can be used in either thermally imageable or photochemically imageable elements.